Company intelligence / Profile preview

Core Clinical Trials

Ownership: Private
Development stage: Commercial

Overview

Core Clinical Trials is an investigator-owned network of clinical research sites that partners with healthcare professionals, research organizations, and pharmaceutical companies to conduct high-quality, patient-focused clinical trials. The company emphasizes diversity, inclusion, advanced technology adoption (including Direct to Patient® access), and operational excellence. It has been recognized for rapid growth by making the Inc. 5000 list in 2023. No proprietary drug development or internal pipeline is indicated—CCT facilitates trials for external sponsors across multiple therapeutic areas.

Therapeutic areas: Other
Modalities: Not specified; depends on sponsor studies
Industry: Contract Research Organization

Partnerships

Partnerships with leading healthcare professionals, research organizations, pharmaceutical companies

Beyond the preview

Go deeper on Core Clinical Trials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core Clinical Trials.

Explore the full profile